BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25219767)

  • 1. Genome-wide CNV analysis in 221 unrelated patients and targeted high-throughput sequencing reveal novel causative candidate genes for colorectal adenomatous polyposis.
    Horpaopan S; Spier I; Zink AM; Altmüller J; Holzapfel S; Laner A; Vogt S; Uhlhaas S; Heilmann S; Stienen D; Pasternack SM; Keppler K; Adam R; Kayser K; Moebus S; Draaken M; Degenhardt F; Engels H; Hofmann A; Nöthen MM; Steinke V; Perez-Bouza A; Herms S; Holinski-Feder E; Fröhlich H; Thiele H; Hoffmann P; Aretz S
    Int J Cancer; 2015 Mar; 136(6):E578-89. PubMed ID: 25219767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing identifies potential novel candidate genes in patients with unexplained colorectal adenomatous polyposis.
    Spier I; Kerick M; Drichel D; Horpaopan S; Altmüller J; Laner A; Holzapfel S; Peters S; Adam R; Zhao B; Becker T; Lifton RP; Holinski-Feder E; Perner S; Thiele H; Nöthen MM; Hoffmann P; Timmermann B; Schweiger MR; Aretz S
    Fam Cancer; 2016 Apr; 15(2):281-8. PubMed ID: 26780541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
    Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
    Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-level APC mutational mosaicism is the underlying cause in a substantial fraction of unexplained colorectal adenomatous polyposis cases.
    Spier I; Drichel D; Kerick M; Kirfel J; Horpaopan S; Laner A; Holzapfel S; Peters S; Adam R; Zhao B; Becker T; Lifton RP; Perner S; Hoffmann P; Kristiansen G; Timmermann B; Nöthen MM; Holinski-Feder E; Schweiger MR; Aretz S
    J Med Genet; 2016 Mar; 53(3):172-9. PubMed ID: 26613750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing.
    Rohlin A; Rambech E; Kvist A; Törngren T; Eiengård F; Lundstam U; Zagoras T; Gebre-Medhin S; Borg Å; Björk J; Nilbert M; Nordling M
    Fam Cancer; 2017 Apr; 16(2):195-203. PubMed ID: 27696107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexplained polyposis: a challenge for geneticists, pathologists and gastroenterologists.
    Mongin C; Coulet F; Lefevre JH; Colas C; Svrcek M; Eyries M; Lahely Y; Fléjou JF; Soubrier F; Parc Y
    Clin Genet; 2012 Jan; 81(1):38-46. PubMed ID: 21476993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis.
    Adam R; Spier I; Zhao B; Kloth M; Marquez J; Hinrichsen I; Kirfel J; Tafazzoli A; Horpaopan S; Uhlhaas S; Stienen D; Friedrichs N; Altmüller J; Laner A; Holzapfel S; Peters S; Kayser K; Thiele H; Holinski-Feder E; Marra G; Kristiansen G; Nöthen MM; Büttner R; Möslein G; Betz RC; Brieger A; Lifton RP; Aretz S
    Am J Hum Genet; 2016 Aug; 99(2):337-51. PubMed ID: 27476653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of adenomatous polyposis coli and MUTYH mutations in familial colorectal polyposis.
    De Rosa M; Galatola M; Borriello S; Duraturo F; Masone S; Izzo P
    Dis Colon Rectum; 2009 Feb; 52(2):268-74. PubMed ID: 19279422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.
    Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA
    Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal adenomatous polyposis syndromes: Genetic determinism, clinical presentation and recommendations for care.
    Buecher B
    Bull Cancer; 2016 Feb; 103(2):199-209. PubMed ID: 26805944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first mutations in the MYH gene reported in Moroccan colon cancer patients.
    Laarabi FZ; Cherkaoui Jaouad I; Baert-Desurmont S; Ouldim K; Ibrahimi A; Kanouni N; Frebourg T; Sefiani A
    Gene; 2012 Mar; 496(1):55-8. PubMed ID: 22266422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of MYH germline mutations in Swiss APC mutation-negative polyposis patients.
    Russell AM; Zhang J; Luz J; Hutter P; Chappuis PO; Berthod CR; Maillet P; Mueller H; Heinimann K
    Int J Cancer; 2006 Apr; 118(8):1937-40. PubMed ID: 16287072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hereditary forms of colorectal adenomatous polyposis].
    Kohoutová M; Stekrová J; Sulová M; Zidková K; Kleibl Z; Vandrovcová J; Kebrdlová V; Kotlas J; Jirásek V
    Cas Lek Cesk; 2006; 145(6):475-9. PubMed ID: 16836001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing.
    Rey JM; Ducros V; Pujol P; Wang Q; Buisine MP; Aissaoui H; Maudelonde T; Olschwang S
    J Mol Diagn; 2017 Jul; 19(4):589-601. PubMed ID: 28502729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative familial colorectal cancer patients.
    Thean LF; Loi C; Ho KS; Koh PK; Eu KW; Cheah PY
    Genes Chromosomes Cancer; 2010 Feb; 49(2):99-106. PubMed ID: 19847890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas.
    Spier I; Holzapfel S; Altmüller J; Zhao B; Horpaopan S; Vogt S; Chen S; Morak M; Raeder S; Kayser K; Stienen D; Adam R; Nürnberg P; Plotz G; Holinski-Feder E; Lifton RP; Thiele H; Hoffmann P; Steinke V; Aretz S
    Int J Cancer; 2015 Jul; 137(2):320-31. PubMed ID: 25529843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH.
    Sieber OM; Lipton L; Crabtree M; Heinimann K; Fidalgo P; Phillips RK; Bisgaard ML; Orntoft TF; Aaltonen LA; Hodgson SV; Thomas HJ; Tomlinson IP
    N Engl J Med; 2003 Feb; 348(9):791-9. PubMed ID: 12606733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
    Nielsen M; Hes FJ; Nagengast FM; Weiss MM; Mathus-Vliegen EM; Morreau H; Breuning MH; Wijnen JT; Tops CM; Vasen HF
    Clin Genet; 2007 May; 71(5):427-33. PubMed ID: 17489848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations.
    Thirlwell C; Howarth KM; Segditsas S; Guerra G; Thomas HJ; Phillips RK; Talbot IC; Gorman M; Novelli MR; Sieber OM; Tomlinson IP
    Br J Cancer; 2007 Jun; 96(11):1729-34. PubMed ID: 17505512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline variation in the oxidative DNA repair genes NUDT1 and OGG1 is not associated with hereditary colorectal cancer or polyposis.
    Mur P; Jemth AS; Bevc L; Amaral N; Navarro M; Valdés-Mas R; Pons T; Aiza G; Urioste M; Valencia A; Lázaro C; Moreno V; Puente XS; Stenmark P; Warpman-Berglund U; Capellá G; Helleday T; Valle L
    Hum Mutat; 2018 Sep; 39(9):1214-1225. PubMed ID: 29900613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.